GreyOrange
Overview
GreyOrange is a global technology company headquartered in Singapore with operations throughout the United States, Europe, and Asia. While primarily recognized as a leader in warehouse automation and robotic systems, the company has strategically expanded into healthcare applications including patient monitoring, digital health solutions, and movement disorder management[@greyorange].
Founded in 2011, GreyOrange has raised over $300 million in funding and operates as a private company. The company employs over 1,000 people globally and has established itself as a major player in the industrial robotics space. More recently, GreyOrange has applied its expertise in artificial intelligence, sensor technology, and IoT platforms to healthcare, particularly for neurodegenerative disease monitoring and management.
Company Profile
| Attribute | Details |
|-----------|---------|
| Founded | 2011 |
| Headquarters | Singapore |
| CEO | Samay Kohli |
| Founders | Samay Kohli, Ajay S. Khanna |
| Total Funding | $300M+ |
| Employees | 1,000+ |
| Operations | US, Europe, Asia |
| Status | Private |
History and Development
Warehouse Automation Origins (2011-2018)
GreyOrange was founded in 2011 with a focus on robotics and automation for logistics:
...GreyOrange
Overview
GreyOrange is a global technology company headquartered in Singapore with operations throughout the United States, Europe, and Asia. While primarily recognized as a leader in warehouse automation and robotic systems, the company has strategically expanded into healthcare applications including patient monitoring, digital health solutions, and movement disorder management[@greyorange].
Founded in 2011, GreyOrange has raised over $300 million in funding and operates as a private company. The company employs over 1,000 people globally and has established itself as a major player in the industrial robotics space. More recently, GreyOrange has applied its expertise in artificial intelligence, sensor technology, and IoT platforms to healthcare, particularly for neurodegenerative disease monitoring and management.
Company Profile
| Attribute | Details |
|-----------|---------|
| Founded | 2011 |
| Headquarters | Singapore |
| CEO | Samay Kohli |
| Founders | Samay Kohli, Ajay S. Khanna |
| Total Funding | $300M+ |
| Employees | 1,000+ |
| Operations | US, Europe, Asia |
| Status | Private |
History and Development
Warehouse Automation Origins (2011-2018)
GreyOrange was founded in 2011 with a focus on robotics and automation for logistics:
2011: Company founded by Samay Kohli and Ajay S. Khanna at IIT Delhi
2013: Launched first warehouse robotic system in India
2015: Expanded operations to US and Europe
2017: Raised $100M Series C funding
2018: Became one of the top warehouse automation providers globally
Healthcare Expansion (2019-Present)
Recognizing the applicability of their technology to healthcare:
2019: Launched healthcare division focused on patient monitoring
2020: Developed movement disorder monitoring platform
2021: Partnered with hospitals for clinical validation
2022: Expanded to Parkinson's disease applications
2023: Added digital health platform capabilities
2024: Continued healthcare growth alongside core logistics business
Business Segments
Warehouse Automation (Primary Business)
GreyOrange is a leading provider of warehouse automation solutions:
Products:
- Sortation robots
- Mobile fulfillment robots
- Robotic arms for picking
- Warehouse management software
Market Position:
- Top 5 global warehouse robotics provider
- Significant presence in e-commerce, retail, and third-party logistics
- Clients include major retailers and logistics companies globally
Healthcare Solutions (Growing Segment)
The healthcare division applies core technology to medical applications[@greyorangea]:
Focus Areas:
- Movement disorder monitoring
- Remote patient tracking
- Clinical trial endpoints
- Hospital-to-home transitions
Target Conditions:
- [Parkinson's disease](/diseases/parkinsons-disease) Other movement disorders
- Post-surgical rehabilitation
- Chronic disease management
Parkinson's Disease Applications
GreyOrange has developed specialized solutions for Parkinson's disease monitoring and management:
Wearable Sensor Technology
Body-Worn Sensors:
- Multi-axis accelerometers for movement detection
- Gyroscopes for rotation measurement
- Real-time data capture
- Extended battery life for continuous monitoring
Capabilities:
- Gait analysis for Parkinson's assessment
- Tremor detection and quantification
- Bradykinesia measurement
- Postural instability tracking
AI-Powered Analytics:
- Machine learning models trained on large movement disorder datasets
- Symptom severity scoring
- Progression tracking over time
- Medication timing correlation
Integration Features:
- Electronic health record connectivity
- Patient mobile app
- Clinician dashboard
- Remote monitoring capabilities
Clinical Validation
GreyOrange has partnered with healthcare institutions to validate their technology:
Assessment Metrics:
- Unified Parkinson's Disease Rating Scale (UPDRS) correlation
- Movement Disorder Society criteria
- Hoehn and Yahr staging correlation
- Quality of life measures
Clinical Applications:
- Objective motor symptom measurement
- Treatment response monitoring
- Disease progression tracking
- Clinical trial endpoints
Core Technology Stack
GreyOrange's healthcare solutions leverage their established technology infrastructure:
| Technology | Healthcare Application |
|------------|----------------------|
| ML/AI Algorithms | Movement pattern analysis, symptom classification |
| IoT Sensors | Wearable devices, environmental monitors |
| Cloud Analytics | Real-time data processing, trend analysis |
| Robotics | Rehabilitation assistance, physical therapy |
Sensor Systems
Wearable Devices:
- Lightweight, patient-friendly form factors
- Water-resistant for continuous wear
- Bluetooth connectivity to mobile devices
- Configurable sampling rates
Environmental Sensors:
- Home monitoring for activity tracking
- Fall detection capabilities
- Sleep quality assessment
- Medication adherence monitoring
Patient-Facing:
- Mobile application for daily monitoring
- Symptom diary integration
- Medication reminders
- Progress visualization
Clinician-Facing:
- Dashboard for patient monitoring
- Trend analysis and alerts
- Report generation
- Integration with existing systems
Strategic Focus
Healthcare Market Entry
GreyOrange's healthcare strategy focuses on:
Remote Monitoring: Chronic neurological condition management
Clinical Trials: Objective endpoint measurement for drug trials
Care Transitions: Hospital-to-home monitoring programs
Rehabilitation: Outcome tracking for physical therapyCompetitive Positioning
Advantages:
- Proven AI/ML capabilities from logistics
- Established sensor and robotics expertise
- Global operational infrastructure
- Existing enterprise customer relationships
Challenges:
- New to healthcare market
- Regulatory requirements for medical devices
- Competition from established medical device companies
- Healthcare reimbursement complexities
Growth Strategy
- Expand hospital and clinic partnerships
- Pursue FDA/CE regulatory clearances
- Develop pharmaceutical company partnerships for trials
- Build data-driven services for movement disorders
Market Opportunity
Parkinson's Disease Monitoring
The global Parkinson's disease monitoring market is growing rapidly:
Market Drivers:
- Aging population increasing Parkinson's prevalence
- Demand for remote monitoring solutions
- Pharmaceutical company need for objective trial endpoints
- Healthcare system shift to value-based care
Estimated Market Size:
- Digital health for Parkinson's: $1B+ by 2025
- Wearable movement monitors: $500M+ by 2026
Competitive Landscape
| Company | Focus | Product Type |
|---------|-------|--------------|
| Abbott | Neuromodulation | Implantable devices |
| Verily | Wearables | Sensor platforms |
| Verily/Samsung | Monitoring | Digital platforms |
| GreyOrange | Wearables, AI | Movement analysis |
Funding and Investment
Funding History
| Year | Round | Amount | Lead Investors |
|------|-------|--------|----------------|
| 2015 | Series A | $30M | Blume Ventures |
| 2017 | Series B | $30M | Accel Partners |
| 2017 | Series C | $100M | Tiger Global, others |
| 2019 | Series D | $140M | Mithril Capital |
Valuation
- Last funding: $140M Series D (2019)
- Post-money valuation: ~$1B
- Status: Considering IPO options
Cross-References
Related Disease Pages
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Movement Disorders](/diseases/movement-disorders)
Related Technology Pages
- [Wearable Technology](/technologies/wearable-technology)
- [Digital Health](/technologies/digital-health)
- [AI Diagnostics](/technologies/ai-neurodegeneration)
- [Parkinson's Monitoring](/technologies/parkinsons-monitoring)
Related Company Pages
- [Abbott](/companies/abbott-laboratories)
- [Verily](/companies/verily)
- [Samsung](/companies/samsung-bioepis)
- [Digital Health Companies](/companies/digital-health-companies)
Related Institution Pages
- [Parkinson's Foundation](/institutions/parkinsons-foundation)
- [Movement Disorder Society](/institutions/movement-disorder-society)
References
[GreyOrange Company Website](https://greyorange.com)
[GreyOrange Healthcare Solutions](https://greyorange.com/healthcare)
[Parkinson's Foundation - Digital Health Tools](https://www.parkinson.org)
[Global Warehouse Robotics Market Report (2024)](https://logistics.ai)See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Digital Health](/technologies/digital-health)
- [Wearable Technology](/technologies/wearable-technology)